ProShares Ultra Health Care (NYSEARCA:RXL – Get Free Report) shares passed above its 50-day moving average during trading on Friday. The stock has a 50-day moving average of $59.86 and traded as high as $65.11. ProShares Ultra Health Care shares last traded at $64.22, with a volume of 11,248 shares trading hands.
ProShares Ultra Health Care Stock Performance
The stock’s fifty day moving average price is $59.86 and its 200-day moving average price is $52.99. The firm has a market cap of $102.11 million, a PE ratio of 24.86 and a beta of 1.10.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Toth Financial Advisory Corp purchased a new position in ProShares Ultra Health Care in the third quarter valued at about $535,000. Envestnet Asset Management Inc. boosted its stake in shares of ProShares Ultra Health Care by 2.0% during the 2nd quarter. Envestnet Asset Management Inc. now owns 10,859 shares of the company’s stock worth $576,000 after acquiring an additional 212 shares in the last quarter. Citadel Advisors LLC grew its holdings in shares of ProShares Ultra Health Care by 12.7% in the 2nd quarter. Citadel Advisors LLC now owns 9,273 shares of the company’s stock worth $492,000 after acquiring an additional 1,042 shares during the period. Finally, IMC Chicago LLC acquired a new stake in shares of ProShares Ultra Health Care in the 1st quarter worth approximately $3,103,000.
About ProShares Ultra Health Care
ProShares Ultra Health Care (the Fund) seeks daily investment results that correspond to twice (200%) the daily performance of the Dow Jones U.S. Health Care Index (the Index). The Fund intends to invest at least 80% of its net assets, including any borrowings for investment purposes, under normal circumstances, to equity securities contained in the Index and/or financial instruments that, in combination, have similar economic characteristics. The Fund also intends to invest assets not invested in financial instruments, in debt instruments and/or money market instruments.
See Also
- Five stocks we like better than ProShares Ultra Health Care
- Could a Trucking Squeeze Become J.B. Hunt’s Biggest Edge?
- Rocket Lab’s Neutron Delay Leaves Wall Street Bullish But Raises the Stakes for 2027
- ManpowerGroup Stock Sinks on Q3 Results, But Fundamentals Stay Solid
- Does the AI Selloff Put Alphabet’s Breakout in Doubt?
Receive News & Ratings for ProShares Ultra Health Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Health Care and related companies with MarketBeat.com's FREE daily email newsletter.
